10-hydroxycamptothecin has been researched along with docetaxel anhydrous in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Geng, M; Ji, YB; Jiang, JS; Li, H; Lou, GY; Ma, T; Xi, WQ; Xia, HQ; YeE, ZB | 1 |
Chen, Z; Jia, HR; Pan, GY; Ulrich, NW; Wu, FG; Zhu, YX | 1 |
2 other study(ies) available for 10-hydroxycamptothecin and docetaxel anhydrous
Article | Year |
---|---|
[In vitro chemo-sensitivity MTT assay guided intraperitoneal chemotherapy for malignant ascites].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Ascites; Camptothecin; Cell Survival; Colorectal Neoplasms; Docetaxel; Female; Humans; Injections, Intraperitoneal; Kaplan-Meier Estimate; Male; Middle Aged; Pancreatic Neoplasms; Stomach Neoplasms; Taxoids; Tumor Cells, Cultured | 2006 |
Development of a Light-Controlled Nanoplatform for Direct Nuclear Delivery of Molecular and Nanoscale Materials.
Topics: Camptothecin; Cell Line, Tumor; Cell Nucleus; Cell Survival; Docetaxel; Drug Delivery Systems; Fluorescent Dyes; Humans; Light; Nanoparticles; Organosilicon Compounds; Particle Size; Polyamines; Polyethylene Glycols; Rose Bengal; Taxoids | 2018 |